NCT05562999View on ClinicalTrials.gov

Impact of Deep Neuromuscular Blockade During Total Hip Replacement Surgery on Postoperative Recovery and Immune Function

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 18, 2022

Primary Completion Date

August 29, 2024

Study Completion Date

August 29, 2024

Conditions
Neuromuscular BlockadeInnate Inflammatory ResponseQuality of LifePostoperative Complications
Interventions
DRUG

Rocuronium Bromide

Moderate NMB (TOF 1-2)

DRUG

Rocuronium Bromide

Deep NMB (PTC 1-2)

Trial Locations (1)

6500HB

Radboudumc, Nijmegen

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Radboud University Medical Center

OTHER